SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divi’s Laboratories informs about newspaper publication

21 Jul 2021 Evaluate

Divi’s Laboratories has informed that it has enclosed copies of notice to shareholders of the Company published in newspapers intimating that the 31st Annual General Meeting of the Company is scheduled to be held on Monday, August 30, 2021 at 10.00 am IST through video conferencing (VC) / other audio-visual means (OAVM) including other details are attached. This notice was published on July 21, 2021 in the newspapers, ‘Financial Express (English Daily) and Andhra Prabha (Telugu Daily)’.

The above information is a part of company’s filings submitted to BSE.

Divis Lab Share Price

6228.95 -68.55 (-1.09%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×